AKT1 and hepatocellular carcinoma: The PFKFB3/AKT/ERCC1 (Excision repair cross-complementation group 1) pathway has been reported to promote the progression of hepatocellular carcinoma by enhancing DNA repair in the process of glycolysis [40].